Nitric oxide (NO) is known to increase the affinity of the intracellular iron-regulatory protein (IRP) for iron-response elements (IRES) in transferrin receptor and ferritin mRNAs, suggesting that it may act as a regulator of cellular iron metabolism. In this study, exogenous NO produced by adding the NO-generator S-nitroso-N-acetyl penicillamine gave a dose-dependent upregulation of transferrin receptor expression by K562 erythroleukemia cells and increased levels of transferrin receptor mRNA. NO did not affect the affinity of transferrin binding by the transferrin receptor. NO alone did not alter intracellular ferritin levels, but it did abrogate the inhibitory effect of the iron chelator desferriox-ELLULAR IRON HOMEOSTASIS is controlled by the expression of two proteins, the transferrin receptor, which mediates uptake of iron, and ferritin, which serves as a store for iron in excess of that required for immediate metabolic needs.' Expression of both these proteins is regulated in a coordinate but reciprocal manner by a cytoplasmic protein known as iron-regulatory protein (IRP) (also known as the iron-response element-binding protein or iron-regulatory factor), which binds to specific sequences known as iron-response elements (IRES) in the untranslated regions of the mRNAs of these two proteins.* High-affinity binding occurs when cellular iron levels are low; in the case of ferritin mRNA, binding occurs to an IRE in the S' untranslated region and blocks translation,' whereas with the transferrin receptor binding occurs to IRES in the 3' untranslated region and stabilizes the mRNA.4 When iron levels are high, the IRP-IRE affinity is lower, allowing translation of ferritin mRNA but destabilizing transferrin receptor mRNA. IRP is an iron-sulphur protein, and the high-iron form is identical to cytoplasmic a c o n i t a~e .~.~ Furthermore, IRP regulates translation of erythroid &amino levulinate synthase (eALAS) in a similar way to that of ferritin,' thus providing a direct link between the IRE-IRP system and erythropoiesis.
amine and potentiated the stimulatory effect of additional iron. NO also caused some increase in ferritin mRNA levels, which might mask any IRP-/IRE-mediated inhibitory effect of NO on ferritin translation. Although NO did not affect net iron uptake, it increased release of iron from K562 cells pulsed previously with 59Fe, and subcellular fractionation showed that it also increased the proportion of intracellular iron bound to ferritin. These findings provide direct evidence that NO can affect cellular iron metabolism and suggest that NO produced in vivo by activated bone marrow macrophages might affect erythropoiesis. tor produced through the enzymatic action of NO-synthase on L-arginine, can enhance the binding of IRP to the IRE.8.9 This is consistent with the known ability of NO to provoke loss of iron from iron-sulphur proteins." ' These findings suggest a mechanism by which iron homeostasis could be regulated by factors other than iron levels themselves, as occurs, for example, in inflammation. However, although the previous ~t u d i e s~.~ showed an effect on IRP-IRE interactions and on femtin levels, direct effects of NO on transferrin receptor expression and cellular iron metabolism have not been shown thus far.
Therefore, we have investigated the effect of NO on expression of transferrin receptor and ferritin, cellular iron distribution, and iron release using the erythroleukemic cell line KS62. This cell line was chosen because it has been used extensively in previous studies of cellular iron homeostasis, including regulation of IRP activity by NO. In that report,* NO was generated endogenously by activating NO synthase with tetrahydrobiopterin. However, this compound may affect other parameters such as cell proliferation that could alter cellular iron homeostasis and utilization. Therefore, to avoid this problem, we have used the compound S-nitroso-N-acetyl penicillamine (SNAP), which generates NO in solution as a means of exposing cells to NO.
MATERIALS AND METHODS

Materials.
Apotransfemin was obtained from Behringwerke (Hounslow, UK) and was saturated to the required level with iron using Fe-nitrilotriacetate (FeNTA)." Transfemn was labeled with 59Fe using "Fe-citrate and with I2'I by a modified chloramine-T procedure, as described in earlier studies." FeNTA (Fe:NTA ratio, 1:4) was prepared from Na-NTA and freshly prepared FeC1, solutions" and was added to cell cultures at a final concentration of Fe of SO p n o l k . Human serum albumin (HSA; transfemn-free) was obtained from Behringwerke, desfemoxamine (DFO) from CIBA (Horsham, UK), penicillamine from Sigma (Poole, UK), and SNAP from Schwarz-Pharma (Monheim, Germany). Rabbit antihuman ferritin was obtained from Serotec (Oxford, UK), and the Ig fraction was prepared by ammonium sulphate precipitation and coupled to CNBr-activated Sepharose 4B (Pharmacia, Milton Keynes, UK) according to the manufacturer's instructions. Chelex 100 was obtained from Bio-Rad (Gloucester, UK).
Cell cultures. K562 cells were routinely cultured in RPM1 1640 medium (Flow, Rickmansworth, UK) supplemented with antibiotics and 10% fetal calf serum. To avoid problems of variability in levels of iron and transferrin caused by the presence of serum, cells were For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From centrifuged and incubated for 1 hour in serum-free RPM1 1640 containing 1 mg/mL HSA and 50 pg/mL human transferrin (30% iron-saturated) to allow exocytosis of serum components and were then centrifuged, resuspended, and incubated for a further 24 hours in similar medium. This procedure yielded log-phase cultures in serum-free medium, which were used for all experiments.
Transferrin binding. Log-phase cells, obtained as described above, were incubated for a further 24 hours at 106/mL in serumfree medium containing transferrin and HSA. SNAP (IO pmoVL except where otherwise stated), DFO (1 mmoVL), or FeNTA (50 pmoVL Fe) were added as appropriate. The cells were then spun down, washed twice in ice-cold phosphate-buffered saline (PBS) containing 1 mg/mL bovine serum albumin (PBS-A) and 25 p1 aliquots containing 2.5 X lo6 cells incubated with 25 p1 of Iz5I-transfenin (8 pg/mL) on ice for 30 minutes. At the end of this period, the cells were rapidly separated from the supernatant on a cell harvester (Ilacon, Tonbridge, UK) and were washed 5 times with ice-cold PBS-A, and cell-associated activity was determined. In some experiments, cells were incubated with varying amounts of sites was determined by the Scatchard method as described pre~i 0 u s l y . l~ Iron uprake, release, and intracellular disfriburion. Log-phase cells were centrifuged and resuspended at 3 X 105/mL in fresh medium containing HSA and IO pg/mL of transferrin that had been saturated to 30% with 5ve-citrate. The cells were incubated for 6 hours to allow incorporation of '%e, then centrifuged, washed 2 times in warm Hanks' buffered salts solution, and resuspended in fresh medium containing 50 pg/mL of unlabeled transferrin (30% iron-saturated) and HSA plus appropriate additions of test compounds. The cells were incubated for 15 hours, then centrifuged and washed twice in cold Hanks' buffered salts solution. Supernatants and washes were retained for assaying 59Fe activity. The cells were then subjected to lysis and determination of intracellular iron distribution as described by Alvarez-Hernindez et a1.I5 Briefly, this consisted of lysis in PBS containing 1% Triton X-100 and 1 mmoVL DFO, centrifugation at 10, OOOg for 5 minutes, affinity chromatography on Sepharose antiferritin, and ultrafiltration through a 10, OOO molecular weight cut-off filter. This allows separation of intracellular iron into four compartments containing predominantly insoluble material (probably consisting mainly of hemosiderin and iron tightly bound to intracellular organelles), ferritin-bound iron, low molecular weight chelatable iron, and high molecular weight nonferritin iron, respectively. The 59Fe activity in each fraction was determined. Although these fractions do not necessarily contain exclusively the forms of iron stated, the method nevertheless provides a useful means of making comparative analyses of intracellular iron distribution.
Binding of iron compounds by Chelex resin. To 0.3-g aliquots of Chelex resin in 1 mL of PBS containing 1 moVL NaCl was added 0.1 pCi of 59Fe-citrate together with SNAP, penicillamine, or DFO to a final concentration of 10 pmoVL, as appropriate. Transferrin labeled with 59Fe (2.5 p g protein) was also tested under similar conditions.
Determination of intracellular ferritin. This was performed by radioimmunoassay of cell lysates, as described previously.14 Northern blotling. K562 cells were grown in the presence of appropriate additives as described above. After 6 hours, the cells were harvested, and RNA was extracted using RNAzol as described previ0us1y.l~ Samples (10 pg) were run on formaldehyde gels essentially as described by Sambrook et a1,I6 were electroblotted on to a nylon membrane, and were prehybridized for 1 hour at 65" in Church buffer (0.5 m o m Na-phosphatell mmoVL EDTA/7% sodium dodecy1 sulfate). Hybridization was performed overnight in Church buffer containing the appropriate random-primer-labeled DNA probe(s). Transferrin receptor mRNA was detected using an Acc-I fragment of the transferrin receptor TRSl plasmid and ferritin using a fulllength cDNA probe to human H-ferritin. A full-length cDNA to mouse actin and a Pst-I fragment of rat glyceraldehyde 3-phosphate dehydrogenase were used as controls. Band intensities were determined using a phosphorimager (Image-quant, Sunnyvale, CA).
RESULTS
Transferrin binding and intracellular ferritin.
Addition of SNAP to K562 cultures caused a dose-dependent increase in transferrin binding (Fig l) , the effect of 10 pmol/L SNAP being comparable with that of 1 mmol/L DFO (Table 1) . When DFO and SNAP were added together, no further increase in transfenin binding was observed, and SNAP did not abrogate the reduction in transferrin binding caused by 50 pmol/L Fe.
The ability of SNAP to increase transferrin receptor expression was confirmed by Scatchard analysis (Fig 2) , with the number of binding sites per cell increasing by about 41%. SNAP had little effect on the affinity of binding.
In contrast to its effect on transferrin binding, addition of SNAP to K562 cultures had no effect on intracellular ferritin levels compared with control cells, although addition of DFO or iron produced the expected decrease and increase in ferritin levels, respectively (Table 1) * Mean f SD, n = 9. t Mean t SD, n = 6.
* P < .01 compared with control (no addition).
5 P < .05 compared with control (no addition).
tion of SNAP to K562 cultures caused an increase in transferrin receptor mRNA levels. As expected, DFO also caused an increase in transferrin receptor mRNA, and iron decreased levels. Quantification by phosphorimaging showed that transferrin receptor mRNA levels in DFO-and SNAP-treated cultures were 55% and 66% greater than in controls, respectively, whereas that of iron-treated cells was 20% lower. Ferritin mRNA levels were largely unaffected by DFO and iron (-10% and +lo% difference from controls, respectively), but the level in SNAP-treated cells was 29% higher suggesting a possible pretranslational effect of NO. Iron uptake, release, and intracellular distribution. Initial experiments showed that, despite its ability to increase transferrin receptor expression, SNAP did not greatly affect the net amount of iron taken up from transferrin by the cells, uptake per lo7 cells being 8.9% 2 2.2% (n = 5 ) of available iron for the control and 11.5% 2 3.2% in the presence of SNAP. However, an explanation for this became apparent when subsequent iron release and intracellular distribution were examined ( Table 2) ; iron release was 39% greater from cells treated with SNAP than from controls, suggesting that enhanced iron uptake did occur but was offset by a greater release. There was also a significantly greater amount of iron bound to ferritin in SNAP-treated cells than in controls, but there was no corresponding compensatory decrease in any one other cellular compartment, all of which showed small but, statistically, not significant decreases compared with the control.
SNAP does not act as an iron chelator. Because SNAP is a derivative of penicillamine, a compound with the potential to act as an iron chelator, it was important to establish that the effects caused by addition of SNAP were not simply due to iron chelation rather than release of NO. Therefore, the effect of SNAP and penicillamine on iron binding by Chelex 100 resin, which binds free or weakly complexed iron but not high-affinity complexes, was studied. In the presence of transferrin or DFO less than 5% of iron was bound to Chelex, whereas greater than 95% of iron in the form of ferric citrate or s9Fe added to SNAP or penicillamine was bound by the resin. Thus any iron-chelating ability of SNAP or penicillamine must be very weak and certainly not comparable with that of DFO. Furthermore, penicillamine caused no increase in transferrin binding to K562 cells (38.6 2 1.2 ng/106 cells [n = 91 for control v 38.6 2 
ng/lOh
ORlA ET AL cells for penicillamine) or in iron release (102% I 16% [n = 41 relative to the control). Therefore, it seems that the effects of SNAP on transfenin binding and cellular iron metabolism were mediated by NO rather than iron chelation.
DISCUSSION
Iron homeostasis is maintained by regulating the mechanisms by which cells take up, store, and release iron. The most important molecules involved in this process are the transferrin receptor, which permits cellular uptake of transferrin-bound iron,I7 and ferritin, which detoxifies and stores iron acquired in excess of that needed for cellular metabolism.'* Both these proteins are regulated at the posttranscnptional level by IRP, thus enabling iron itself to control the homeostatic mechanisms. ' However, there are some instances where alterations in cellular iron metabolism occur that are not directly related to changes in iron status. In particular, inflammatory and bound/free immunologic stimuli cause a slowing of iron release from sites of storage and absorption.'"'" The mechanisms mediating these changes are unclear but probably involve increased ferritin synthesis and iron retention caused by the action of cytokines such as interleukin-l" or tumor necrosis factorwhich may upregulate both transcription23 and translation" of ferritin. Further insight has been gained recently with the finding that NO can activate IRE-binding by converting IRP to the high-affinity form'.') and thus regulate ferritin translation.* indicating the existence of a link between a molecule involved in inflammatory processes and translational regulation of cellular iron metabolism.
The work reported here provides direct evidence for such a link. We have shown that SNAP, a compound that produces NO in solution, increased transferrin receptor expression by K562 cells, a finding consistent with the previously reported ability of endogenously produced NO in these cells to convert IRP to the form with high affinity for the IRE.' However, such upregulation ought also to lead to a concomitant decrease in ferritin translation and, thus, to reduced cellular ferritin levels, as was indeed previously found to occur in a murine macrophage cell line in which endogenous NO production had been activated and in an IRE-chloramphenicol acetyl transferase (CAT) construct in K562 cells.x In the present work, treatment of K562 cells with SNAP did not appreciably alter ferritin levels: moreover, SNAP both abrogated the downregulatory effect of DFO and potentiated the effect of iron. Metabolic labeling experiments also indicated that ferritin synthesis in SNAP-treated cells was similar to that in controls (data not shown). The reasons for this are not clear, but it is of interest that SNAP caused an increase in ferritin mRNA levels, which may offset decreased translation mediated by IRP. Previous work suggests that total IRP levels in K562 cells are relatively low compared with those in macrophage cell lines,' and it may be that, if IRP levels are limiting, transferrin receptor is regulated more efficiently than ferritin. Alterations in cellular iron kinetics may also play a role, as discussed below.
With respect to ferritin, these findings differ from those reported earlier in the murine 5774 macrophage cell line, in which NO markedly decreased ferritin biosynthesis.' However, in those experiments, NO was produced endogenously by activating the cells with lipopolysaccharide and y-interferon, which causes a marked NO-independent increase in ferritin mRNA levels.* This could mask any effect of NO on transcription, and, indeed, in fibroblasts transfected with NO-synthase that constitutively produce NO, there is also a modest NO-mediated increase in ferritin mRNA levels (Pantopoulos and Hentze, unpublished data). Thus, the role of NO in ferritin gene expression may involve effects beyond those related to IRE-IRP interactions.
Despite the increased expression of transferrin receptor resulting from exposure of the cells to SNAP, there was no corresponding net increase in iron uptake. This appears to be because of the fact that SNAP-treated cells released significantly more iron than control cells, a finding that is in keeping with earlier reports showing that activated macrophages subjected to stimuli now known to result in NO release can provoke iron release from tumor cells. '5,2h Therefore, NO may have the effect of increasing iron flux through the cell rather than of provoking a net increase in iron uptake or release.
The main effect of SNAP on the intracellular distribution of iron in K562 cells was a significant (albeit not particularly substantial) increase in the proportion of iron associated with ferritin. The most likely explanation for this is that iron mobilized by NO from cellular iron compounds is subsequently reincorporated into ferritin. NO interacts with cellular iron compounds to yield iron-nitroso complexes, but these can undergo ligand exchange and could, thus, yield their iron to ferritin."'This may partly explain the failure of SNAP to decrease ferritin levels, despite the ability of NO to activate IRP, because the released iron may eventually overcome the translational block resulting from activation of IRP by NO. The fact that SNAP potentiated the effect of Fe on fenitin levels supports this explanation; however, it is possible in this case that nonspecific interactions of the cells with FeNTA, used to produce iron-loaded cells, might also affect ferritin synthesis, and it needs to be explained why transferrin receptor expression was nevertheless increased by NO. Furthermore, NO may also mobilize iron from ferritin": therefore, it is unclear what the net effect of NO might be For personal use only. on September 24, 2017. by guest www.bloodjournal.org From on ferritin-iron. The ability of NO to increase ferritin mRNA levels, reported here, may be important because it could counterbalance any inhibition of ferritin translation. Evidently, the effect of NO on cellular iron homeostasis is complex and cannot be wholly explained by its direct effect on IRP. Detailed studies of the dynamics of IRP conversion by NO in relation to transferrin receptor and ferritin synthesis and to uptake and release of iron will be required to address this problem.
Although increased NO production in vivo occurs during inflammation, these changes in cellular iron metabolism induced in K562 cells by exogenously produced NO do not in themselves mirror the increased ferritin synthesis, iron retention, and inhibition of erythropoiesis observed in inflammation. However, the effects of inflammation on ferritin and transferrin receptor are mediated mainly by mechanisms that do not involve the IREORP system and are, therefore, not likely to be influenced by N0.23.24.28 Thu S, whereas inflammatory cytokines can reduce iron release from macrophages and uptake by erythroid p r e c u r s~r s , '~~~~~~~ NO may help to mediate a counterbalancing mechanism by restoring normal iron release from macrophages and, thus, delivery to the erythroid marrow. This is consistent with our earlier in vitro studies showing that, whereas inflammatory macrophages showed increased iron uptake and retention, immunologically activated macrophages showed increased uptake but also an increased re1ea~e.I~ On the other hand, the presence of an IRE in the 5'-untranslated region of eALAS mRNA' suggests that NO might inhibit eALAS translation, which would depress rather than restore erythropoiesis. Therefore, although NO released by macrophages in the bone marrow might help to restore an adequate supply of iron to erythroid precursors, it might also potentiate the anemia. Future studies of how NO affects expression of eALAS may help to clarify its role in the anemia of chronic disease.
